medline.ch Neurologie Alzheimer

	Stage-Dependent Cognitive Effects of a Multinutrient Intervention in Alzheimer's Disease: A Stage-Stratified Meta-Analysis. J Vis Exp Han P, Dong P, Zhou Y, Zhang L, Mahomed O. PMID: 42683892 [PubMed - in process]
	A world view: Considerations of sociocultural diversity in the study of subjective cognitive decline in Alzheimer's disease and related dementias. Alzheimers Dement Dubbelman MA, Hill-Jarrett TG, Chapman S, Alves Andrade Dos Santos G, Azar M, Babulal GM, Bell TR, Bernard MA, Boza-Calvo C, Briggs AQ, Bubu OM, Cuevas HE, Dowling NM, Esiaka DK, Fausto BA, de Oliveira FF, Franz CE, Furlano JA, Gonzalez-Corona C, Guest MA, Gupta VB, Gupta VK, Jackson D, Joyce JL, Kann MR, Kremen WS, Lee A, Martinez JE, Masurkar AV, McLin MA, Resende EPF, Rahemi Z, Renfro BC, Aliberti MJR, Shagalow S, Slachevsky A, Talarico JNS, Trani JF, Van Hulle C, Waltrip L, Wandera SO, Windon CC, Yassuda MS, Moretti DV, Kuhn E, Butterbrod E, Gifford KA, Sikkes SAM, Castilhos RM, Nosheny R, Stites SD, a collaboration of the Alzheimer's Association International Society to Advance Alzheimer's Research and Therapy Subjective Cognitive Decline and Diversity and Disparities Professional Interest Areas. PMID: 42683545 [PubMed - indexed for MEDLINE]
	The highest clinical trial failure rate for any disease in modern medicine: How both amyloid- and non-amyloid-targeting therapies failed to alter disease course in Alzheimer's disease. Free Neuropathol Guth MAS. PMID: 42683436 [PubMed]
	From amyloid PET to plasma biomarkers: A multimodal imaging framework for early diagnosis and staging of Alzheimer's disease. Alzheimers Dement (Amst) Liu J, Xu C, Wang Y, Zhang J, Hui R, Lv W, Xu A, Dang Y, Su S, Zhao H, Gao Y, Zhang J. PMID: 42683384 [PubMed]
	Aquaporin dysfunction and impaired brain interstitial fluid clearance in Alzheimer's disease - an integrative review. Front Cell Neurosci Manescu MD, Minca T, Pirici I, Busuioc CJ, Mateescu VO, Pirici D. PMID: 42683218 [PubMed]
	Comment on "The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs". Int J Surg Han J, Wang M, Wu Z. PMID: 42682345 [PubMed]
	Proteome-wide genetic study identified therapeutic targets for early-onset and late-onset Alzheimer's disease. Int J Surg Chen L, Sun H, Fang MJ, Cheng N, Xu Y. PMID: 42682321 [PubMed]
	Brain-Targeting siRNA Delivery to Tackle Alzheimer's Disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol Yang Q, Chen Z, Zhu J, Chai T, Tang F, Fan M, Li Y, Chen S, Liu Y, Zheng M. PMID: 42682011 [PubMed - indexed for MEDLINE]
	Curcumin nanoformulations for modulating neuroinflammation and oxidative stress in Alzheimer's disease: blood-brain barrier transport, formulation strategies and therapeutic applications. Inflammopharmacology Begum MY, Rajkumar M, Govindaraj P, Prathap N, Sudha PN, Al Hamod M, Alotaibi H, Uvarajan D. PMID: 42680958 [PubMed - as supplied by publisher]
	Symptomatic treatment for Alzheimer disease: current evidence and future directions. Nat Rev Neurol Ballard C, Doherty P, Ismail Z, Corbett A, Cummings JL. PMID: 42680930 [PubMed - as supplied by publisher]
	The Gut Microbiota and Gut-Brain Axis in Alzheimer's Disease: From Pathogenesis to Treatment. Ageing Res Rev Wang J, Luo L, Zhang J, Yu L, Cui L. PMID: 42680070 [PubMed - as supplied by publisher]
	Cross-tissue multi-omics integration highlights BPHL and mitochondrial targets in Alzheimer's disease. Psychiatry Res Neuroimaging Wang B, Yuan F, Zhou W, Pan Y. PMID: 42679757 [PubMed - as supplied by publisher]
	Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome. Neurology Wagemann O, Nuebling GS, Sandkühler K, Wlasich E, Loosli SV, Prix C, Stockbauer AC, Marth L, Forte A, Vöglein J, Katzdobler S, Bernhardt AM, Martinez-Murcia FJ, Jiménez-Mesa C, Höglinger GU, Levin J. PMID: 42679336 [PubMed - indexed for MEDLINE]
	Non-pharmacological interventions for sleep improvement in Alzheimer's disease: A systematic review and meta-analysis. J Alzheimers Dis Zhang Q, Zhou Q, Yang M, Zou S, Li Y, Wang Z. PMID: 42678693 [PubMed - as supplied by publisher]
	Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes. Drugs Hey JA, Abushakra S, Power A, Watson D, Porsteinsson A, Sabbagh M, MacSweeney E, Cohen S, Boada M, Doraiswamy PM, Elahi FM, Rissman RA, Liang E, Flint S, Hristova E, Kesslak P, McLaine R, Albayrak A, Schaefer JF, Yu JY, Tolar L, Tolar M. PMID: 42678603 [PubMed - as supplied by publisher]
	Phosphatidylethanolamine-mediated metabolic membrane remodeling in obesity-associated Alzheimer's disease: mechanisms, neuroimmune crosstalk, and therapeutic potential. Metab Brain Dis Ahmad M, Aijaz M, Ansari MA, Afzal M. PMID: 42678458 [PubMed - indexed for MEDLINE]
	Brain-derived plasma p-tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological change. Alzheimers Dement Denkinger MN, Brum WS, Leuzy A, Singh A, Marques TM, Ghisays V, Protas H, Su Y, Atri A, Beach TG, Serrano GE, Bhatt K, Carlson CM, Hoffmann K, Reiman EM, Ashton NJ. PMID: 42677463 [PubMed - indexed for MEDLINE]
	L-theanine attenuates AlCl3-induced cognitive dysfunction and neurotoxicity in rats: a behavioral and biochemical study. Turk J Med Sci Dönmez MO, , Karaman Ersoy , Marzi M, . PMID: 42677254 [PubMed - indexed for MEDLINE]
	Comment on "The Diagnostic Performance of the AlzoSure Predict Assay and Its Association With Alzheimer's Disease Biomarkers and Imaging Findings". Health Sci Rep Khan MA, Sher N. PMID: 42676569 [PubMed]
	P2X7 receptor-dependent microglia-astrocyte coupling in Alzheimer's disease: from eATP sensing to synaptic and proteostatic failure. Front Aging Neurosci Li Y, Liu S, Lan J. PMID: 42676531 [PubMed]

Artikel 1 - 20 / 72057

Seite 1 von 3603

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung